Acupuncture or ear acupuncture for weight loss in Polycystic Ovary Syndrome
- Conditions
- Polycystic Ovary SyndromeOverweightObesityMetabolic and Endocrine - Metabolic disordersAlternative and Complementary Medicine - Other alternative and complementary medicineReproductive Health and Childbirth - Other reproductive health and childbirth disorders
- Registration Number
- ACTRN12618000975291
- Lead Sponsor
- ICM Health Research Institute, Western Sydney University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- Female
- Target Recruitment
- 29
women aged 18-45 years
•physician diagnosis of PCOS according to the 2003 Rotterdam Criteria in previous 5 years
•BMI greater than 25 kg/m2; no other endocrine disorders;
•not pregnant/no pregnancies in preceding 6 weeks and more than 6 weeks postpartum;
•no breastfeeding within the last 6 weeks;
not on the following medications in the 3 months preceding enrolment: metformin or other medications affecting insulin and glucose metabolism, hormonal treatments for PCOS/ART including gonadotrophins and the Oral Contraceptive Pill, pharmaceutical or complementary therapies for weight loss
•Planning to conceive within the next 3 months
•Needle acupuncture in the previous 3 weeks
•Unable to provide informed consent.
•BMI >40
•anticoagulant use
•pacemaker use
•immunocompromise
•valvular heart disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recruitment rates calculated as : number of women enrolled per month of active recruitment, number of enquiries per month of active recruitment; percentage conversion to enrolment measured as n enrolled/n enquiries and n enrolled/n potentially eligible.[3 months post-intervention commencement];Acceptability assessed by an exit survey designed specifically for the study[3 months post-intervention commencement];Retention rate calculated as number of women remaining in study at 3 months post intervention as a proportion of number of women who enrolled in the study[3 months post-intervention commencement]
- Secondary Outcome Measures
Name Time Method